Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

85 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Guidelines for the management of Helicobacter pylori-related upper gastrointestinal diseases. Irish Helicobacter Pylori Study Group.
Buckley M, Culhane A, Drumm B, Keane C, Moran AP, O'Connor HJ, Collins J, Kelleher D, McAvinchey D, Sloan J, O'Morain C. Buckley M, et al. Ir J Med Sci. 1996 Oct-Dec;165 Suppl 5:1-11. Ir J Med Sci. 1996. PMID: 8990665 Review.
Treatment of Helicobacter pylori infection.
Egan BJ, Marzio L, O'Connor H, O'Morain C. Egan BJ, et al. Helicobacter. 2008 Oct;13 Suppl 1:35-40. doi: 10.1111/j.1523-5378.2008.00639.x. Helicobacter. 2008. PMID: 18783520
Practical treatment of Helicobacter pylori: a balanced view in changing times.
Smith SM, Haider RB, O'Connor H, McNamara D, O'Morain C. Smith SM, et al. Eur J Gastroenterol Hepatol. 2014 Aug;26(8):819-25. doi: 10.1097/MEG.0000000000000130. Eur J Gastroenterol Hepatol. 2014. PMID: 24892516 Review.
Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland.
O'connor A, Taneike I, Nami A, Fitzgerald N, Murphy P, Ryan B, O'connor H, Qasim A, Breslin N, O'morĂ¡in C. O'connor A, et al. Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1123-7. doi: 10.1097/MEG.0b013e328338e43d. Eur J Gastroenterol Hepatol. 2010. PMID: 20354442
Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
Qasim A, Sebastian S, Thornton O, Dobson M, McLoughlin R, Buckley M, O'Connor H, O'Morain C. Qasim A, et al. Aliment Pharmacol Ther. 2005 Jan 1;21(1):91-6. doi: 10.1111/j.1365-2036.2004.02210.x. Aliment Pharmacol Ther. 2005. PMID: 15644050
Coeliac disease in Europe.
McLoughlin R, Sebastian SS, Qasim A, McNamara D, O'Connor HJ, Buckley M, O'Morain C. McLoughlin R, et al. Aliment Pharmacol Ther. 2003 Nov;18 Suppl 3:45-8. doi: 10.1046/j.1365-2036.18.s3.1.x. Aliment Pharmacol Ther. 2003. PMID: 14531740 Review. No abstract available.
Review article: test and treat or test and scope for Helicobacter pylori infection. Any change in gastric cancer prevention?
Mc Loughlin RM, Sebastian SS, O'Connor HJ, Buckley M, O'Morain CA. Mc Loughlin RM, et al. Aliment Pharmacol Ther. 2003 Jun;17 Suppl 2:82-8. doi: 10.1046/j.1365-2036.17.s2.13.x. Aliment Pharmacol Ther. 2003. PMID: 12786618 Review.
Helicobacter pylori and nonmalignant diseases.
Alakkari A, Zullo A, O'Connor HJ. Alakkari A, et al. Among authors: o connor hj. Helicobacter. 2011 Sep;16 Suppl 1:33-7. doi: 10.1111/j.1523-5378.2011.00878.x. Helicobacter. 2011. PMID: 21896083 Review.
A randomized-controlled study to compare the efficacy of sequential therapy with standard triple therapy for Helicobacter pylori eradication in an Irish population.
Haider RB, Brennan DE, Omorogbe J, Holleran G, Hall B, O'Morain C, Breslin N, O'Connor HJ, Smith SM, McNamara D. Haider RB, et al. Among authors: o connor hj. Eur J Gastroenterol Hepatol. 2015 Nov;27(11):1265-9. doi: 10.1097/MEG.0000000000000457. Eur J Gastroenterol Hepatol. 2015. PMID: 26287955 Clinical Trial.
85 results
Jump to page
Feedback